Article Details
Retrieved on: 2024-04-17 14:08:39
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Pfizer; AbbVie; F. Hoffmann-La Roche. Myasthenia Gravis Treatment Market Insights. Monoclonal antibodies will remain the largest segment over the ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here